Results 21 to 30 of about 497,503 (208)

Seroprevalence and trend of human immunodeficiency virus among blood donors in Ethiopia: a systematic review and meta-analysis

BMC Infectious Diseases, 2019
Background Blood transfusion is one of the routine therapeutic interventions in hospitals that can be lifesaving. However, this intervention is related to several transfusion-related infections.
Henok Mulugeta, Getenet Dessie, Fasil Wagnew, Dube Jara, Cheru Tesema Leshargie, Ayenew Negesse   +5 more
doaj   +1 more source

Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection [PDF]

, 2003
Liver-related mortality is an increasing problem in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)-coinfected patients receiving highly active antiretroviral therapy (HAART).
Bertoletti, A, Gilson, RJ, Lascar, RM, Lopes, AR, Maini, MK   +4 more
core   +1 more source

Concluding Remarks for Special Issue HTLV-HIV Co-Infections

Viruses, 2023
During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV) [...]
Alejandro Vallejo, María Abad-Fernández   +1 more
doaj   +1 more source

Voluntary Counselling and Testing for HIV Among Allied Workers in Rural Area of Nigeria: Evaluation of Community-Based Interventions

International Journal of Occupational Safety and Health, 2020
Introduction: Knowledge of human immunodeficiency virus status is a key tool in the fight against the spread of the human immunodeficiency virus epidemic.
Ali Johnson Onoja , Felix Olaniyi Sanni , Paul Olaiya Abiodun , Sheila Onoja , John Shaibu , Daniel Oguche , Imam Adamu   +6 more
doaj   +3 more sources

Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications [PDF]

, 2015
One-fourth of individuals diagnosed with the human immunodeficiency virus concomitantly have the hepatitis C virus infection. Since the discovery of highly active antiretroviral therapy, liver complications have become the leading cause of morbidity and ...
Gandhi, Mona A., Kaur, Kirpal, Slish, Judianne   +2 more
core   +2 more sources

Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles [PDF]

, 2002
BACKGROUND: Cellulose acetate phthalate (CAP), a promising candidate microbicide for prevention of sexual transmission of the human immunodeficiency virus type 1 (HIV-1) and other sexually transmitted disease (STD) pathogens, was shown to inactivate HIV ...
A Nicholls, A Robert Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AS Dimitrov, Asim K Debnath, CE Parker, CH Chen, CM Carr, CM Carr, DC Chan, DC Chan, DL LeDuc, DR Littman, E de Rosny, EG Cormier, EG Cormier, GB Melikyan, H Deng, I Munoz-Barroso, J Bentz, J Chen, JA McKeating, JJ Skehel, K Tan, KH Manson, M Farzan, M Lu, M Thali, MK Gorny, Nathan Strick, P Lusso, PD Kwong, PL Jones, QJ Sattentau, QJ Sattentau, QJ Sattentau, R Wyatt, R Wyatt, RA Furuta, RL Willey, RW Doms, S Gartner, S Jiang, S Jiang, SA Gallo, Shibo Jiang, SL Orloff, SP Layne, T Gyotoku, T Kawamura, T Korte, T Weber, T-C Chou, TN Hart, U Moebius, VA Johnson, W Weissenhorn, W Weissenhorn, X-Z Pan, Y Kliger, Yun-Yao Li   +67 more
core   +3 more sources

Moderate restriction of macrophage-tropic human immunodeficiency virus type 1 by SAMHD1 in monocyte-derived macrophages.

PLoS ONE, 2014
Macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains are able to grow to high titers in human monocyte-derived macrophages. However, it was recently reported that cellular protein SAMHD1 restricts HIV-1 replication in human cells of the ...
Kahoru Taya, Emi E Nakayama, Tatsuo Shioda   +2 more
doaj   +1 more source

Safety and practicality of an excisional lymph node study driving HIV cure research in South Africa

Frontiers in Immunology
IntroductionStudying diseased human tissues offers better insights into the intricate interactions between pathogens and the human host. In conditions such as HIV and cancers, where diseases primarily manifest in tissues, peripheral blood studies are ...
Trevor Khaba, Andrea Olga Papadopoulos, Thandeka Nkosi, Sifundo Nxele, Thandekile Ngubane, Ismail Jajbhay, Johan Pansegrouw, Zaza M. Ndhlovu, Zaza M. Ndhlovu, Zaza M. Ndhlovu   +9 more
doaj   +1 more source

Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj. [PDF]

PLoS ONE, 2009
BACKGROUND: Human primary monocytes are refractory to infection with the human immunodeficiency virus 1 (HIV-1) or transduction with HIV-1-derived vectors.
Silke Schüle, Björn-Philipp Kloke, Julia K Kaiser, Sabine Heidmeier, Sylvia Panitz, Nina Wolfrum, Klaus Cichutek, Matthias Schweizer   +7 more
doaj   +1 more source

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Alvar, Bachani, Berman, Bern, Bora, Braitstein, C. Ferreyra, D. Remartinez, G. Mitra, Hurissa, Ikomi, J. van Griensven, K. Pandey, L. Flevaud, Lin, Lyons, M. Pece, Mathur, N. Kumar, N. Verma, P. Das, P. K. Sinha, P. Kumar, P. P. Palma, Pintado, R. Kumar, R. Mahajan, Redhu, Sinha, Sinha, Sundar, Sundar, ter Horst, Thakur, van Griensven   +34 more
core   +2 more sources